TIPS FOR COMPLETING CRF’S October 30 2015. Antimicrobial Report Form 7  In iDataFax use the drop-down list to record the Antimicrobial Code. This will.

Slides:



Advertisements
Similar presentations
Consolidation Communicable Diseases User Stories: Meeting Agenda 1.News from other domains 2.Recap of a previous meeting 3.Consolidation of three more.
Advertisements

1 What’s New in the Therapy Prior Authorization Review Process? December 2011 Therapy Clinical Webinars.
Clinical Documentation Improvement Program Physician Program Overview Our CDI program works to ensure the documentation in the medical record captures.
Measurement: the why and the what
James Marx, PhD, RN, CIC Broad Street Solutions October 2014.
C. difficile Lab ID Reporting in NHSN Stanley Ostrawski RN, MS, MT(ASCP), CIC Infection Preventionist Consultant.
HAI Surveillance & Definitions In LTCF
Developed by Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: September 2009 Most recently updated: October 2013.
Case Report Form Start-up Meeting March 25, 2010 Kingston, ON.
Utilize the Electronic Health Record (EHR) to improve nursing process and patient outcomes. CATHETER ASSOCIATED URINARY TRACT INFECTION (CAUTI): A PREVENTION.
Trial Procedures and Forms
ACRIN 6698 Diffusion-weighted MRI Biomarkers for Assessment of Breast Cancer Response to Neoadjuvant Treatment: An I-SPY 2 Trial Substudy Presented by:
CSA Release 2 CYBER Training. Training Purpose Review the new functionality in CYBER that will assist in the submission and review of Treatment Plans.
HEALTH CARE ASSOCIATED INFECTION دکترافشین محمد علیزاده متخصص عفونی عضوهیئت علمی دانشگاه علوم پزشکی شهیدبهشتی بیمارستان آیت ا...طالقانی.
Revised 10/20/04Version 2.4Page 1 of 22 People First Manual Timesheet Training Guide Section 2 -- Training Scenarios.
Part I BACKGROUND VENTILATOR ASSOCIATED PNEUMONIA.
MTN-027 Laboratory Related CRFs. Pharmacokinetics Specimens (PKS-1) - Enrollment, Day 28 Pharmacokinetics Specimens (PKD-1) - Days 1, 2, 3, 7, 14, 21,
The Transition to What you need to know for Gynecology Date | Presenter Information.
The Transition to What you need to know for Pulmonary Medicine Date | Presenter Information.
The Transition to What you need to know for Endocrinology Date | Presenter Information.
The Transition to What you need to know for Nephrology Date | Presenter Information.
Monthly Statistical Summary Report (MSSR) Tips and Guidelines June 2013.
THE UTI MODULE LECTURE. To outline the aims of the UTI module To describe the questionnaires LECTURE OBJECTIVES.
Investigator’s Meeting
The Transition to What you need to know for Infectious Disease Date | Presenter Information.
Infection Adjudication on REDCAP Module 1 Version: Feb 1st, 2012.
Childcare And Family Information Service Anne Lalley Choice Adviser.
Cohort 1A-C Coaching Call October 1, 2014 Facilitators: Lisa Carhuff Kathy McGowan Joyce Reid.
1) Complete all steps of the verification process Two webinars available on the Verification Process: Verification Process – What is involved?
CERNER™ PowerOrders Orders Status Interface June 8, 2009.
Mette Krag, MD, coordinating investigator
MTN-028 Laboratory Related CRFs. Pharmacokinetics Specimens (PKS-1) - Enrollment, Day 28 Pharmacokinetics Specimens (PKD-1) - Days 1, 2, 3, 7, 14, 21,
Face to Face (F2F) Documentation Changes for Physicians.
Time for first antibiotic dose is not predictive for the early clinical failure of moderate–severe community-acquired pneumonia Eur J Clin Microbial Infect.
Laboratory diagnoses of infections agents. DIFFERENT TYPES OF AND APPROACHES TO CLINICAL SAMPLE COLLECTION.
The AHRQ Safety Program for Improving Antibiotic Use
NHSN Reporting for Critical Access Hospitals
Søren Marker Jensen, MD, coordinating investigator
HIV acutely unwell pathway Sussex HIV Network This pathway applies to all patients other than those listed in non-acute pathway All HIV+ patients with.
Source: AMA: Steps Forward
The Good, the Bad and the How can we do better? (RRAILs audit)
Clostridium difficle Isolation precautions
30 April 2015 Updated 29 December 2015
Face to Face (F2F) Documentation Changes for Physicians
HOW TO ENTER BASELINE DATA
Face to Face (F2F) Documentation Changes for Physicians
The AHRQ Safety Program for Improving Antibiotic Use
The AHRQ Safety Program for Improving Antibiotic Use
22 MAY – 5 JUNE 2017 A South African national, multi-centre fourteen day evaluation of patient care and clinical outcomes for paediatric patients undergoing.
Key points.
ADMISSIONS ONLINE APPLICATION SYSTEM
Key points.
OUT-PATIENT IN A BED (OIB) PROCESS.
HOW TO ENTER BASELINE DATA
Hospital Antibiotic Stewardship Programs
بنام خداوند جان و خرد بنام خداوند جان و خرد.
Copenhagen University Hospital Rigshospitalet, Denmark
CareConnection Screen Shots
Using CareConnection for Documentation
Using CareConnection for Documentation
Ordering Sputum Cultures in Community Acquired Pneumonia
E-CRF Overview Oracle® Clinical Remote Data Capture Training (Version 4.6 HTML) e-CRF Completion John McDonach Manager CDM, PPD.
Cerebrospinal fluid Culture
Adverse Event Reporting _____________________________
Cerebrospinal fluid Culture
Module 6: Case Report Form (Chart Abstraction)
Community Acquired Pneumonia
Retrospective Post Payment Claim Review 2019 Q2
Serious Adverse Event Reconciliation
Clinical Documentation Improvement Program In-Patient Status
Presentation transcript:

TIPS FOR COMPLETING CRF’S October

Antimicrobial Report Form 7  In iDataFax use the drop-down list to record the Antimicrobial Code. This will allow the name of the antimicrobial code to automatically be recorded. The antimicrobial name cannot be typed as this field is view only. October

Culture Report Form 8  In iDataFax use the drop-down list to record the Organism Code. Ensure to capture all positive organisms and all positive gram stains. If one culture report indicates more than 3 organisms/gram stains, use more than 1 line. October

 Record Specimen #’s for all positive cultures as well as all negative C-Diff cultures.

 When completing an Infection Outcome Form based upon a positive culture, report the event on the Study Day the culture specimen was collected from the patient.  (e.g., Sputum collected on Day 3, positive results received on Day 5, event should be entered on Day 3) October

Record Post ICU C-Diff Testing, both negative and positive, on Form 14.1 and October Forward copies of all positive culture reports, culture negative/gram stain positive reports and all positive or negative C-Diff Reports to the Methods Centre

October

Daily Data Form 4.1 Question 2  When a value is not available, (i.e. Lab Work), code as missing (leaving blanks will prompt a query).  When only 1 value for Temperature or Leukocytes is available, record same value for both highest and lowest values. October

Stool Classification Form 6.2 Question 1  When Bristol Type is not available, leave the Bristol Type box blank, check the “other” box, specifying “not documented”. October

 When is a Respiratory Infection Outcome Form 9 required? o When a patient is being treated with antimicrobials for a respiratory infection or suspected respiratory infection at time of Randomization - Study Day 1 (This includes Pre-Randomization events).  Review Antimicrobial Report October

o At any time the patient is being treated with antimicrobials for a suspected respiratory infection or a new/worsening respiratory infection while in the ICU.  Review Antimicrobial Report o When a physician suspects a respiratory infection while patient is in the ICU, even when culture negative.  Review Physician/RN Progress Notes October

o Each time a new organism related to a respiratory infection is identified on a positive culture report.  Review Culture Report o When a chest x-ray indicates a new or worsening consolidation or infiltrate.  Review Chest X-Ray October

 Timeframe for Clinical Pulmonary Infection Score (CPIS) – Form 9.1 Question 3 o Worst CPIS scores are determined by reviewing the data up to and including 48 hours prior the event.  i.e., CPIS data is collected on the day the Respiratory Infection was recorded and 48 hours prior.. October

o When a patient has a suspected or treated respiratory infection on the day of randomization, worst CPIS scores are determined by reviewing data on Study Day 1 and up to 48 hours prior to randomization.  48 hours prior to event could include data from either the ER or Ward or ICU. Do not use data from other hospitals October

o For new or worsening events post- randomization, worst CPIS scores are determined by reviewing data on the day the respiratory infection is recorded and including up to 48 hours prior event.  48 hours prior event suspected on Study Day 2 could include data from ER or Ward. Do not use data from other hospitals. October

o To help determine the CPIS Score, a worksheet is available on the Respiratory Infection Outcome Form 9.2. This worksheet is optional not mandatory. October

 Timeframe for SIRS Criteria – Form 9.1 Question 5 o SIRS Criteria data is obtained by reviewing 24 hours before to 24 hours after date of suspected infection. October

o When a patient has a suspected or treated respiratory infection on the day of randomization, SIRS Criteria data is determined by reviewing data from up to 24 hours prior to randomization to 24 hours after Study Day 1.  24 hours prior to event could include data from either the ER or Ward or ICU. Do not use data from other hospitals. October

o To help determine the SIRS Criteria, a worksheet is available on the Respiratory Infection Outcome Form 9.2. This worksheet is optional not mandatory. October

 Was there at least 1 microorganism identified? – Form 9.1 Question 8 o Ensure to capture positive gram stains and/or positive cultures October

Infection Outcome Forms Blood Stream Form 10 Intra-Abdominal Form 11 Urinary Tract Form 12 Skin and Soft Tissue Form 13 Other Form 20 October

 When are Infection Outcome Forms required? o When a patient is being treated with antimicrobials for an infection at time of Randomization - Study Day 1 (This includes Pre-Randomization events).  Review Antimicrobial Report October

o When a physician suspects an infection while patient is in the ICU, even when culture negative.  Review Physician/RN Progress Notes October o At any time the patient is being treated with antimicrobials for a suspected infection or a new/worsening infection while in the ICU.  Review Antimicrobial Report

o Each time a new organism related to an infection is identified on a positive culture report.  Review Culture Report October

Clostridium Difficile Outcome Form 14 October

When is a Clostridium Difficile (C-Diff) Outcome Form 14 and required? o When a patient is being treated with antimicrobials for a C-Diff Infection or suspected C-Diff infection at time of Randomization - Study Day 1 (This includes Pre-Randomization events).  Review Antimicrobial Report October

o When a positive or negative C-Diff has been identified on a culture report while patient is in ICU or any time during the hospitalization.  Review Culture Report October o At any time the patient is being treated with antimicrobials for a suspected C-Diff infection or new C-Diff infection while in the ICU.  Review Antimicrobial Report

How to report a Negative Clostridium Difficile o Response to Question 1 will be No o Question 2 (Which test was this based upon?) will be answered accordingly o Questions 3 and 4 will be left blank ( Question 4 and 5 will be left blank on the Clostridium Difficile Post ICU Discharge Form 14.1) October

SOURCE DOCUMENTS October

ICU Admission Notes and ICU Discharge/Transfer/Notes Please forward ICU Admission Notes and ICU Discharge Notes/Death Summary to the Methods Centre either by fax or via to or October

What Source Documents are required when reporting Infections (please submit to Methods Centre either via fax or via to or o All related Physician/RN Progress Notes o All related Radiology Reports o All related Laboratory Tests o All related Positive Culture Reports o When reporting Clostridium Difficile, include both positive and negative Culture Reports October